Process for the preparation of 1,3-diaza-spiro (4.4) non-1-en-4-one derivatives and 1-cyano-1-acylaminocyclopentane intermediates

Process for the preparation of compounds of formula (I) wherein R means hydrogen atom, or C1-6 alkyl group, or C7-12 aralkyl group or phenyl group, characterised in that a) the compound of formula (III) is reacted with a compound of formula (IV) wherein X means halogen atom or C1-5 alkoxy group or h...

Full description

Saved in:
Bibliographic Details
Main Authors ZSUZSANNA NAD, ZOLTAN MAKOVI, CSABA HUSZAR, ILONA DERVALICSNE ZRINYI, AGNES KUNSZTNE KARASZ, ATTILA KIS-TAMAS, ENDRE KOLLAR, ISTVAN MESZAROS, ATTILA NEMETH, PETER ARANYOSI, ANTAL GAJARY, ERZSEBET BOGNAR, ZSUZSANNA CSETRINE HARI, KAROLY GYURE, ATTILA SUPIC, KATALIN DUBOVSZKI, LAJOSNE PALI
Format Patent
LanguageEnglish
Published 16.02.1999
Edition6
Online AccessGet full text

Cover

Loading…
Abstract Process for the preparation of compounds of formula (I) wherein R means hydrogen atom, or C1-6 alkyl group, or C7-12 aralkyl group or phenyl group, characterised in that a) the compound of formula (III) is reacted with a compound of formula (IV) wherein X means halogen atom or C1-5 alkoxy group or hydroxyl group, and the resulting compound of formula (II) is transformed, in a reaction medium with pH above 7, into the compound of formula (I) or b) the compound of formula (III) is reacted with an anhydride of general formula (V) and the resulting compound of formula (II) transformed, in a reaction medium with pH above 7, into the compound of formula (I), or c) a compound of formula (II) is transformed, in a reaction medium with pH above 7, into the compound of formula (I), and if desired, the resulting compounds of formula (I), before or after isolation, are transformed into acid addition salts, or the compounds of formula (I) are liberated from their acid addition salts. Thus a process for the preparation of intermediates useful in synthesis of angiotensin II antagonists is disclosed.
AbstractList Process for the preparation of compounds of formula (I) wherein R means hydrogen atom, or C1-6 alkyl group, or C7-12 aralkyl group or phenyl group, characterised in that a) the compound of formula (III) is reacted with a compound of formula (IV) wherein X means halogen atom or C1-5 alkoxy group or hydroxyl group, and the resulting compound of formula (II) is transformed, in a reaction medium with pH above 7, into the compound of formula (I) or b) the compound of formula (III) is reacted with an anhydride of general formula (V) and the resulting compound of formula (II) transformed, in a reaction medium with pH above 7, into the compound of formula (I), or c) a compound of formula (II) is transformed, in a reaction medium with pH above 7, into the compound of formula (I), and if desired, the resulting compounds of formula (I), before or after isolation, are transformed into acid addition salts, or the compounds of formula (I) are liberated from their acid addition salts. Thus a process for the preparation of intermediates useful in synthesis of angiotensin II antagonists is disclosed.
Author ATTILA KIS-TAMAS
ATTILA SUPIC
CSABA HUSZAR
ZOLTAN MAKOVI
ANTAL GAJARY
KAROLY GYURE
ENDRE KOLLAR
LAJOSNE PALI
ZSUZSANNA NAD
KATALIN DUBOVSZKI
ERZSEBET BOGNAR
PETER ARANYOSI
ILONA DERVALICSNE ZRINYI
ZSUZSANNA CSETRINE HARI
ISTVAN MESZAROS
AGNES KUNSZTNE KARASZ
ATTILA NEMETH
Author_xml – fullname: ZSUZSANNA NAD
– fullname: ZOLTAN MAKOVI
– fullname: CSABA HUSZAR
– fullname: ILONA DERVALICSNE ZRINYI
– fullname: AGNES KUNSZTNE KARASZ
– fullname: ATTILA KIS-TAMAS
– fullname: ENDRE KOLLAR
– fullname: ISTVAN MESZAROS
– fullname: ATTILA NEMETH
– fullname: PETER ARANYOSI
– fullname: ANTAL GAJARY
– fullname: ERZSEBET BOGNAR
– fullname: ZSUZSANNA CSETRINE HARI
– fullname: KAROLY GYURE
– fullname: ATTILA SUPIC
– fullname: KATALIN DUBOVSZKI
– fullname: LAJOSNE PALI
BookMark eNqFjD0LwjAQQDPo4Ndv8EYFI5S2WMciiqODznKkVwy0dyEJhbr5z83g7vSW995cTViYZupz82IoBGjFQ3wROE8OPUYrDNJCtst1Y_GNOjjrBTbFvthCanWmiXWh0wUa8nZIyUABkBvItBmRJSloxg57y2JG04kjjph8y5F8T-kbKSzVtMUu0OrHhVpfzvfTVZOTJwWHhpjis35UZZkfjlWd_ze-NtFIUw
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
Edition 6
ExternalDocumentID AU8553798A
GroupedDBID EVB
ID FETCH-epo_espacenet_AU8553798A3
IEDL.DBID EVB
IngestDate Fri Jul 19 13:05:59 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_AU8553798A3
Notes Application Number: AU19980085537
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19990216&DB=EPODOC&CC=AU&NR=8553798A
ParticipantIDs epo_espacenet_AU8553798A
PublicationCentury 1900
PublicationDate 19990216
PublicationDateYYYYMMDD 1999-02-16
PublicationDate_xml – month: 02
  year: 1999
  text: 19990216
  day: 16
PublicationDecade 1990
PublicationYear 1999
RelatedCompanies SANOFI
RelatedCompanies_xml – name: SANOFI
Score 2.4996052
Snippet Process for the preparation of compounds of formula (I) wherein R means hydrogen atom, or C1-6 alkyl group, or C7-12 aralkyl group or phenyl group,...
SourceID epo
SourceType Open Access Repository
Title Process for the preparation of 1,3-diaza-spiro (4.4) non-1-en-4-one derivatives and 1-cyano-1-acylaminocyclopentane intermediates
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19990216&DB=EPODOC&locale=&CC=AU&NR=8553798A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3PS8MwFH7MKepNpzJ_5yBFwahr0649DNnajSHsB7LJbqNNUhxIOraqzJv_ua9Zp152KaUtKUnz-n0v770vAFeeJxBomEcdNxKU2bFLo_gBD6YwuVe1EOOyauRO12kP2dPIHhXgdVULo3VCP7U4IloUR3tP9f96-reIFejcyvl9NMFLyWNrUAsMkZeLeQhZjhE0as1-L-j5hu-jJ2l0n2uubVtVz61vwCaS6GqW_NV8aWQ1KdP_gNLag60-tqXSfShIVYIdf7XvWgm2O3m4G09zy5sfwHee0U-QZBIkbWQ6k0vZ7kSRJCaVW4vip_4KaRY6T8g1u2M3BH17dN6koowmShKB0-1DK33PSagEqVC-CFWCj4R8gVNjohK-4G_ZjlrIGSXJtCRmurYECekhXLaaA79NsS_j32Eb14erTltHUMQXyjIQLhCN0MmKPBayLAKDfCWy0OxdMza5FR9DeV0rJ-tvncLuUs7ApBXnDIrp7F2eI1in0YUe5x8hDJnn
link.rule.ids 230,309,783,888,25578,76884
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3PT8IwFH5BNOJNUYM_6cEsmliVrRvbgRjYIKj8igHDbdm6LZKYjsDU4M3_3Lcy1AuXpdmaLu369n2vr-8rwIVlBQg0zKKG6QeU6ZFJ_egOL2qgcquqIcal2cjdntEescexPs7B6yoXRuqEfkpxRLQojvaeyP_19G8Ry5F7K-e3_gRvxfetYc1RgixdzELIMhSnUWsO-k7fVmwbPUml91wzdV2rWmZ9AzaRYJupyn7zpZHmpEz_A0prF7YG2JZI9iAXiiIU7NW5a0XY7mbhbixmljffh-9sRz9BkkmQtJHpLFzKdseCxBGpXGsUP_WXR9PQeUwu2Q27Iujbo_MWCspoLEIS4HT7kErfc-KJgFQoX3gixioeX-DUmIiYL_hbeqIWcsaQpFoSM5lbgoT0AMqt5tBuU-yL-ztsbn206rR2CHl8YVgCwgNEI3SyfIt5LI3AIF_xNTR7U41UrkVHUFrXyvH6R2UotIfdjtt56D2dwM5S2kClFeMU8snsPTxD4E78cznmP4ETnNc
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Process+for+the+preparation+of+1%2C3-diaza-spiro+%284.4%29+non-1-en-4-one+derivatives+and+1-cyano-1-acylaminocyclopentane+intermediates&rft.inventor=ZSUZSANNA+NAD&rft.inventor=ZOLTAN+MAKOVI&rft.inventor=CSABA+HUSZAR&rft.inventor=ILONA+DERVALICSNE+ZRINYI&rft.inventor=AGNES+KUNSZTNE+KARASZ&rft.inventor=ATTILA+KIS-TAMAS&rft.inventor=ENDRE+KOLLAR&rft.inventor=ISTVAN+MESZAROS&rft.inventor=ATTILA+NEMETH&rft.inventor=PETER+ARANYOSI&rft.inventor=ANTAL+GAJARY&rft.inventor=ERZSEBET+BOGNAR&rft.inventor=ZSUZSANNA+CSETRINE+HARI&rft.inventor=KAROLY+GYURE&rft.inventor=ATTILA+SUPIC&rft.inventor=KATALIN+DUBOVSZKI&rft.inventor=LAJOSNE+PALI&rft.date=1999-02-16&rft.externalDBID=A&rft.externalDocID=AU8553798A